Tecchuu Lee
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Concurrent trastuzumab deruxtecan-induced interstitial lung disease and COVID-19 in the treatment of advanced breast cancer.
Journal: Oxford medical case reports
Published: May 16, 2023
Everolimus for Treating Hormone Receptor-positive Metastatic Breast Cancer Previously Treated With Cyclin-dependent Kinase 4/6 Inhibitors.
Journal: Anticancer research
Published: May 30, 2022
Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01.
Journal: Breast cancer (Tokyo, Japan)
Published: October 19, 2019
Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study.
Journal: Breast cancer : basic and clinical research
Published: February 17, 2018
Ectopic gastrointestinal variceal bleeding with portal hypertension.
Journal: World journal of gastrointestinal surgery
Published: August 26, 2017
Evaluation of the Clinical Utility of the ICG Fluorescence Method Compared with the Radioisotope Method for Sentinel Lymph Node Biopsy in Breast Cancer.
Journal: Annals of surgical oncology
Published: April 30, 2015
Erratum to: Outcomes of trastuzumab therapy in HER2‑positive early breast cancer patients.
Journal: International journal of clinical oncology
Published: March 17, 2015
Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients.
Journal: International journal of clinical oncology
Published: November 19, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026